RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 9.5

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

-0.03 (-0.27%)

USD 1.12B
SOXS Direxion Daily Semiconductor B..

-0.20 (-0.88%)

USD 0.75B
PSQ ProShares Short QQQ

-0.10 (-0.25%)

USD 0.62B
SPXU ProShares UltraPro Short S&P50..

-0.17 (-0.67%)

USD 0.53B
SDOW ProShares UltraPro Short Dow30

-0.06 (-0.44%)

USD 0.29B
SPDN Direxion Daily S&P 500® Bear ..

-0.02 (-0.17%)

USD 0.16B
RWM ProShares Short Russell2000

+0.08 (+0.42%)

USD 0.16B
DOG ProShares Short Dow30

-0.03 (-0.11%)

USD 0.16B
DUST Direxion Daily Gold Miners Ind..

+0.05 (+0.95%)

USD 0.14B
YANG Direxion Daily FTSE China Bear..

-0.44 (-5.80%)

USD 0.11B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.37% 53% F 9% A-
Dividend Return 2.66% 81% B- 53% F
Total Return -17.71% 56% F 10% F
Trailing 12 Months  
Capital Gain -26.24% 67% D+ 7% C-
Dividend Return 3.41% 72% C 49% F
Total Return -22.83% 67% D+ 8% B-
Trailing 5 Years  
Capital Gain -78.74% 56% F 4% F
Dividend Return 1.97% 55% F 6% D-
Total Return -76.77% 56% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 1.87% 41% F 45% F
Dividend Return 2.90% 41% F 39% F
Total Return 1.03% 55% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 249.67% 61% D- 3% F
Risk Adjusted Return 1.16% 39% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.